Your browser doesn't support javascript.
loading
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.
Bristol, Jillian A; Djavadian, Reza; Albright, Emily R; Coleman, Carrie B; Ohashi, Makoto; Hayes, Mitchell; Romero-Masters, James C; Barlow, Elizabeth A; Farrell, Paul J; Rochford, Rosemary; Kalejta, Robert F; Johannsen, Eric C; Kenney, Shannon C.
Afiliação
  • Bristol JA; Department of Oncology in Wisconsin Institutes for Medical Research, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Djavadian R; Department of Oncology in Wisconsin Institutes for Medical Research, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Albright ER; Department of Molecular Virology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Coleman CB; Department of Immunology & Microbiology, University of Colorado School of Medicine, Denver, Colorado, United States of America.
  • Ohashi M; Department of Oncology in Wisconsin Institutes for Medical Research, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Hayes M; Department of Oncology in Wisconsin Institutes for Medical Research, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Romero-Masters JC; Department of Oncology in Wisconsin Institutes for Medical Research, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Barlow EA; Department of Pathology and Laboratory Medicine, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Farrell PJ; Department of Oncology in Wisconsin Institutes for Medical Research, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Rochford R; Molecular Virology, Department of Medicine, Imperial College London, London, United Kingdom.
  • Kalejta RF; Department of Immunology & Microbiology, University of Colorado School of Medicine, Denver, Colorado, United States of America.
  • Johannsen EC; Department of Immunology and Microbiology, University of Colorado, Aurora, Colorado United States of America.
  • Kenney SC; Department of Molecular Virology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
PLoS Pathog ; 14(7): e1007179, 2018 07.
Article em En | MEDLINE | ID: mdl-30052684
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Viral / Transativadores / Infecções por Vírus Epstein-Barr Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Viral / Transativadores / Infecções por Vírus Epstein-Barr Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article